Novarel Market Report 2026

Novarel Market Overview

• The Novarel market growth in the historic period has been driven by expansion of fertility treatment clinics, established clinical use of hCG therapies • Market expansion is supported by increasing adoption of advanced fertility treatments, rising maternal age trends • Growth Driver: Rising Prevalence Of Infertility Is Driving The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Novarel Market?

Novarel is a brand name for a medication containing human chorionic gonadotropin (hCG). It is commonly used in fertility treatments. hCG is a hormone that plays a crucial role in the reproductive system, particularly in the regulation of ovulation in women and the production of testosterone in men. It is administered through an injection, and its use is carefully monitored by a healthcare professional to ensure its effectiveness and minimize side effects. The main indications of novarel are induction of ovulation, hypogonadotropic hypogonadism, and fertility preservation. Ovulation induction uses hormonal therapy to stimulate egg development and release, or ovulation. It is distributed through hospitals, pharmacies, and online pharmacies, catering to various end users such as adults and geriatrics.

What Is The Novarel Market Growth Forecast?

The growth in the forecast period can be attributed to increasing adoption of advanced fertility treatments, rising maternal age trends, expansion of personalized fertility protocols, growing investments in reproductive health services, increasing demand for outpatient fertility therapies. Major trends in the forecast period include increasing demand for fertility hormone therapies, growing use of injectable gonadotropins, expansion of assisted reproductive treatments, rising focus on hormone monitoring protocols, enhanced clinical customization of fertility care.

Global Novarel Market Segmentation

1) By Indication: Induction Of Ovulation, Hypogonadotropic Hypogonadism, Fertility Preservation 2) By Distribution Channel: Hospital, Pharmacies, Online Pharmacies 3) By End User: Adult, Geriatric

What Are The Drivers Of The Novarel Market?

The rising prevalence of infertility is expected to raise the growth of the novarel market going forward. Infertility refers to the inability to conceive after one year of regular, unprotected sexual intercourse or the inability to carry a pregnancy to full term. The rising global infertility rates are driving increased demand for fertility treatments, particularly ovulation induction with hCG (such as Novarel), as women seek solutions to overcome ovulation difficulties. Novarel helps treat infertility by stimulating ovulation in women who have difficulty releasing eggs and supporting sperm production in men with low testosterone levels, thereby increasing the chances of conception. For instance, in April 2023, according to the World Health Organization (WHO), about 17.5 % of the adult population globally equivalent to roughly 1 in 6 people experience infertility. Therefore, the rising prevalence of infertility is driving the novarel industry. Rising healthcare spending is expected to boost the growth of the novarel market going forward. Rising healthcare spending is driven by factors such as the increasing prevalence of chronic diseases, the aging population, and the advancement of medical technologies. Healthcare spending supports novarel by enabling access to effective infertility treatments, including the use of human chorionic gonadotropin (hCG), which helps stimulate ovulation and improve fertility outcomes, ultimately leading to more efficient and targeted care in reproductive medicine. For instance, in May 2024, according to a report published by Office For National Statistics, a UK-based government agency, total healthcare spending rose by 5.6% in nominal terms from 2022 to 2023, a notable acceleration compared with the 0.9% increase recorded in 2022. Therefore, rising healthcare spending is driving the novarel industry. The rising number of drug approvals is expected to raise the growth of the novarel market going forward. Drug approvals refer to the process by which regulatory authorities, such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), review and authorize a new drug for sale and use. The rising number of drug approvals is driven by advancements in technology, increased investment in healthcare, streamlined regulatory processes, a focus on precision medicine, growing global demand for treatments, and the expansion of therapies for rare diseases. Drug approvals for Novarel validate its efficacy and safety in treating infertility, ensuring its availability for clinical use. For instance, in October 2024, according to ClinicalTrials.gov, a US-based government clinical trials registry, during 2023 a total of 39,710 new studies were registered, bringing the cumulative total to 477,203 studies by the end of 2023, compared to 38,023 new studies registered during 2022 which brought the cumulative total to 437,493 studies by the end of 2022. Therefore, the rising number of drug approvals is driving the novarel industry.

Key Players In The Global Novarel Market

Major companies operating in the novarel market are Ferring Pharmaceuticals Inc.

Regional Insights

North America was the largest region in the novarel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Novarel Market?

The novarel market consists of sales of novarel (HCG) injection, novarel pre-filled kits, customized dosage forms, and supportive accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Novarel Market Report 2026?

The novarel market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the novarel industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.